Completed OBSERVATIONAL NCT04764747

Effectiveness of Convalescent Plasma in Hospitalized Patients With COVID-19

Evaluating Effectiveness of Convalescent Plasma and Factors Influencing Therapeutic Outcome in Hospitalized Patients With COVID-19

Sponsor: Kufa University

Conditions Covid19

Updated 4 times since 2021 Last updated: May 29, 2021 Started: Nov 1, 2020 Primary completion: Apr 25, 2021 Completion: Apr 25, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Covid19 and is currently completed. Kufa University leads this study, which shows 4 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2021 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Mar 2021 — Sep 2021 [monthly]

Recruiting

First recorded

Nov 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kufa University

Data source: Kufa University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Najaf, Iraq